Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Astellas Pharma Inc. : half-yearly earnings release

10/27/2020 | 09:15am EST

The company will report its earnings for S1 2020 on 10/30/2020. Generally, the company reports earnings in line with the consensus. In recent months, the 11 analysts from Standard & Poor's consensus have not revised their EPS estimates.


© MarketScreener.com 2020
All news about ASTELLAS PHARMA INC.
11/26ASTELLAS PHARMA : Launches a 'Contact for Potential Acquisition of ' R&D Program..
AQ
11/18Japan shares fall as virus surge, firmer yen weigh
RE
11/17ASTELLAS PHARMA : to Present New Data on Gilteritinib in FLT3 Mutation-Positive ..
AQ
11/09ASTELLAS PHARMA INC. : - XTANDI Approved by China NMPA for the Treatment of Non-..
AQ
11/02ASTELLAS PHARMA : Completes Acquisition of iota Biosciences
AQ
10/30Japan stocks fall, post biggest weekly loss in 3 months on virus worries
RE
10/29Japanese shares slump on virus worries, mixed earnings
RE
10/28ASTELLAS PHARMA : Receives U.S. FDA Fast Track Designation for ASP5354, an Inves..
AQ
10/27ASTELLAS PHARMA INC. : half-yearly earnings release
10/23ASTELLAS PHARMA : ITI Announces Promotion of Dr. Tim Coleman to SVP, Operations ..
AQ
More news
Financials
Sales 2021 1 273 B 12 228 M 12 228 M
Net income 2021 194 B 1 861 M 1 861 M
Net cash 2021 444 B 4 264 M 4 264 M
P/E ratio 2021 15,1x
Yield 2021 2,66%
Capitalization 2 935 B 28 214 M 28 186 M
EV / Sales 2021 1,96x
EV / Sales 2022 1,77x
Nbr of Employees 15 883
Free-Float 99,2%
Chart ASTELLAS PHARMA INC.
Duration : Period :
Astellas Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTELLAS PHARMA INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 2 287,50 JPY
Last Close Price 1 580,00 JPY
Spread / Highest target 103%
Spread / Average Target 44,8%
Spread / Lowest Target 7,59%
EPS Revisions
Managers
NameTitle
Kenji Yasukawa President, CEO & Representative Director
Yoshihiko Hatanaka Chairman
Naoki Okamura Representative Director & Vice President
Tomokazu Fujisawa Director
Hiroko Sakai Director
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC.-15.08%28 214
DAIICHI SANKYO COMPANY, LIMITED56.60%72 682
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 850
YUNNAN BAIYAO GROUP CO.,LTD7.23%18 673
ORION OYJ-3.10%6 712
SWEDISH ORPHAN BIOVITRUM AB1.42%5 440